Summary
This amendment to Biogen Inc.'s (BIIB) 8-K filing provides an update on the outcome of an advisory vote concerning the "Say-on-Frequency" proposal presented at its Annual Meeting. The company's stockholders expressed a preference for the "Say-on-Pay" advisory vote to be conducted annually. Consequently, Biogen's Board of Directors has determined that future "Say-on-Pay" votes will indeed be held every year.
Key Highlights
- 1Stockholders favored annual "Say-on-Pay" advisory votes.
- 2Biogen's Board of Directors has accepted this preference.
- 3Future "Say-on-Pay" votes will occur annually.
- 4The Board will re-evaluate this decision by the 2029 annual meeting.
- 5This filing is an amendment (8-K/A) to a previous report.
Frequently Asked Questions
The "Say-on-Pay" vote is an advisory, non-binding shareholder vote on the compensation of the company's named executive officers. It gives shareholders an opportunity to voice their opinion on the company's executive compensation practices.
Biogen's shareholders expressed a preference for the "Say-on-Pay" vote to be held every year.
Biogen's Board of Directors has decided to conduct future "Say-on-Pay" votes on an annual basis, aligning with the shareholders' preference.
The Board of Directors will re-evaluate their determination to hold annual "Say-on-Pay" votes after the next "Say-on-Frequency" Proposal, which is scheduled to occur no later than the 2029 annual meeting of stockholders.